Literature DB >> 1937570

Interleukin-2 receptors on rat eosinophils in adjuvant arthritis.

S C Meacock1, D R Brandon, W Smith.   

Abstract

Monoclonal antibodies specific for the interleukin-2 receptor (IL-2R) have been used to demonstrate by immunohistochemical methods the presence of IL-2R on eosinophils as well as on lymphocytes in lymphoid tissue taken from rats with adjuvant arthritis. Evidence is presented which suggests that the IL-2R on eosinophils may have been induced by the disease process.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1937570      PMCID： PMC1384689     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  13 in total

1.  Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts.

Authors:  D J Paterson; W A Jefferies; J R Green; M R Brandon; P Corthesy; M Puklavec; A F Williams
Journal:  Mol Immunol       Date:  1987-12       Impact factor: 4.407

2.  Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.

Authors:  W W Hancock; W A Muller; R S Cotran
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

3.  Characterization of IL-2 receptor expression and function on murine macrophages.

Authors:  G W Cox; B J Mathieson; S L Giardina; L Varesio
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

4.  Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3.

Authors:  M C Birchenall-Sparks; W L Farrar; D Rennick; P L Kilian; F W Ruscetti
Journal:  Science       Date:  1986-07-25       Impact factor: 47.728

5.  Interleukin 2 receptors on cultured murine epidermal Langerhans cells.

Authors:  G Steiner; E Tschachler; M Tani; T R Malek; E M Shevach; W Holter; W Knapp; K Wolff; G Stingl
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

6.  Establishment and characterization of a new human eosinophilic leukemia cell line.

Authors:  H Saito; A Bourinbaiar; M Ginsburg; K Minato; E Ceresi; K Yamada; D Machover; J Bréard; G Mathé
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

7.  A rapid and simple immunoperoxidase staining procedure for blood and bone marrow samples.

Authors:  U Köller; H Stockinger; O Majdic; P Bettelheim; W Knapp
Journal:  J Immunol Methods       Date:  1986-01-22       Impact factor: 2.303

8.  Differential regulation of the low affinity Fc receptor for IgE (Fc epsilon R2/CD23) and the IL-2 receptor (Tac/p55) on eosinophilic leukemia cell line (EoL-1 and EoL-3).

Authors:  M Hosoda; S Makino; T Kawabe; Y Maeda; S Satoh; M Takami; M Mayumi; K Arai; H Saitoh; J Yodoi
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

9.  Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function?

Authors:  G Tellides; M J Dallman; P J Morris
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

10.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.